Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

P Lorigan; Corinne Faivre-Finn; F Blackhall; L Ashcroft; N Thatcher; P Taylor

Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

P Lorigan, Corinne Faivre-Finn, F Blackhall, L Ashcroft, N Thatcher, P Taylor

Division of Cancer Sciences (L5)

Research output: Contribution to conference › Poster

Original language	English
Publication status	Published - Oct 2011
Event	American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting - Miami, United States Duration: 2 Oct 2011 → 6 Oct 2011

Conference

Conference	American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting
Country/Territory	United States
City	Miami
Period	2/10/11 → 6/10/11

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Lorigan, P., Faivre-Finn, C., Blackhall, F., Ashcroft, L., Thatcher, N., & Taylor, P. (2011). Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC). Poster session presented at American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting, Miami, United States.

Lorigan, P ; Faivre-Finn, Corinne ; Blackhall, F et al. / Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC). Poster session presented at American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting, Miami, United States.

@conference{1606fe0183b8412581db83d6bfd12706,

title = "Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)",

author = "P Lorigan and Corinne Faivre-Finn and F Blackhall and L Ashcroft and N Thatcher and P Taylor",

year = "2011",

month = oct,

language = "English",

note = "American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting ; Conference date: 02-10-2011 Through 06-10-2011",

}

Lorigan, P , Faivre-Finn, C, Blackhall, F, Ashcroft, L, Thatcher, N & Taylor, P 2011, 'Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)', American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting, Miami, United States, 2/10/11 - 6/10/11.

Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC). / Lorigan, P ; Faivre-Finn, Corinne; Blackhall, F et al.
2011. Poster session presented at American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting, Miami, United States.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

AU - Lorigan, P

AU - Faivre-Finn, Corinne

AU - Blackhall, F

AU - Ashcroft, L

AU - Thatcher, N

AU - Taylor, P

PY - 2011/10

Y1 - 2011/10

M3 - Poster

T2 - American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting

Y2 - 2 October 2011 through 6 October 2011

ER -

Lorigan P , Faivre-Finn C, Blackhall F, Ashcroft L, Thatcher N, Taylor P. Long-term toxicity report from a phase II study of accelerated twice-daily (BD) versus high dose once-daily (OD) thoracic radiotherapy (RT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC). 2011. Poster session presented at American Society for Radiation Oncology (ASTRO) 53rd Annual Meeting, Miami, United States.